Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

WeiDong Han

Showing results (301-310 of 371) with videos related to

Pageof 38
Sort By:
Molecular Medicine Reports|September 9, 2020
[Retracted] p53 suppresses stress‑induced cellular senescence via regulation of autophagy under the deprivation of serumXinbing Sui, Yong Fang, Haizhou Lou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2017
Increased IFNγ<sup>+</sup> T Cells Are Responsible for the Clinical Responses of Low-Dose DNA-Demethylating Agent Decitabine Antitumor TherapyXiang Li, Yan Zhang, Meixia Chen, et al.
Expert Opinion on Biological Therapy|December 2, 2014
Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferersYajing Zhang, Lei Xia, Yan Zhang, et al.
Nature Communications|February 27, 2020
Optogenetic engineering to probe the molecular choreography of STIM1-mediated cell signalingGuolin Ma, Lian He, Shuzhong Liu, et al.
Oncology Reports|October 2, 2018
Identification of key tumorigenesis‑related genes and their microRNAs in colon cancerBinbin Xie, Rongjie Zhao, Bingjun Bai, et al.
Oncoimmunology|September 22, 2017
The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancerYan Zhang, Qian Mei, Yang Liu, et al.
Molecular Therapy. Nucleic Acids|September 26, 2022
A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cellsYan Tian, Mingfeng Zhang, Mingjie Fan, et al.
Cancer Letters|November 19, 2025
Manganese mediates nucleoplasm distribution of cGAS to enhance systemic antitumor immunity and drive abscopal effectTiance Wang, Zijian Lv, Runjia Fan, et al.
Journal of Hematology & Oncology|June 12, 2019
Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantationHejin Jia, Zhenguang Wang, Yao Wang, et al.
Journal for Immunotherapy of Cancer|April 6, 2021
Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphomaYang Liu, Chunmeng Wang, Xiang Li, et al.
Pageof 38

Showing results (301-310 of 371) with videos related to

Sort By:
Pageof 38
Molecular Medicine Reports|September 9, 2020
[Retracted] p53 suppresses stress‑induced cellular senescence via regulation of autophagy under the deprivation of serumXinbing Sui, Yong Fang, Haizhou Lou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2017
Increased IFNγ<sup>+</sup> T Cells Are Responsible for the Clinical Responses of Low-Dose DNA-Demethylating Agent Decitabine Antitumor TherapyXiang Li, Yan Zhang, Meixia Chen, et al.
Expert Opinion on Biological Therapy|December 2, 2014
Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferersYajing Zhang, Lei Xia, Yan Zhang, et al.
Nature Communications|February 27, 2020
Optogenetic engineering to probe the molecular choreography of STIM1-mediated cell signalingGuolin Ma, Lian He, Shuzhong Liu, et al.
Oncology Reports|October 2, 2018
Identification of key tumorigenesis‑related genes and their microRNAs in colon cancerBinbin Xie, Rongjie Zhao, Bingjun Bai, et al.
Oncoimmunology|September 22, 2017
The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancerYan Zhang, Qian Mei, Yang Liu, et al.
Molecular Therapy. Nucleic Acids|September 26, 2022
A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cellsYan Tian, Mingfeng Zhang, Mingjie Fan, et al.
Cancer Letters|November 19, 2025
Manganese mediates nucleoplasm distribution of cGAS to enhance systemic antitumor immunity and drive abscopal effectTiance Wang, Zijian Lv, Runjia Fan, et al.
Journal of Hematology & Oncology|June 12, 2019
Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantationHejin Jia, Zhenguang Wang, Yao Wang, et al.
Journal for Immunotherapy of Cancer|April 6, 2021
Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphomaYang Liu, Chunmeng Wang, Xiang Li, et al.
Pageof 38